LUDKA, Ondřej, Jindřich ŠPINAR, Josef TOMANDL a Tomas KONECNY. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients. Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic. Olomouc: Palacký University, 2013, roč. 157, č. 4, s. 325-330. ISSN 1213-8118. Dostupné z: https://dx.doi.org/10.5507/bp.2012.101.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients
Autoři LUDKA, Ondřej (203 Česká republika, garant, domácí), Jindřich ŠPINAR (203 Česká republika, domácí), Josef TOMANDL (203 Česká republika, domácí) a Tomas KONECNY (203 Česká republika).
Vydání Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic, Olomouc, Palacký University, 2013, 1213-8118.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Česká republika
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 1.661
Kód RIV RIV/00216224:14110/13:00071001
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.5507/bp.2012.101
UT WoS 000329091500010
Klíčová slova anglicky Continuous ambulatory peritoneal dialysis; Ejection fraction; Hemodialysis; NT-proBNP
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 13. 4. 2014 11:46.
Anotace
Background. Plasma N-terminal fragment of pro brain natriuretic peptide (NT-proBNP) concentration is elevated in cardiovascular diseases such as congestive heart failure, where increased levels of NT-proBNP indicate cardiac dysfunction, hypervolemia, and higher risk of hospitalization and death. These associations apply also to patients with severe impairment of kidney function. Little is known about diferences in plasma level of NT-proBNP in patients receiving hemodialysis (HD) versus those receiving continuous ambulatory peritoneal dialysis (CAPD). Aim. To evaluate differences in plasma NT-proBNP concentration between HD and CAPD patients. Methods. Plasma NT-proBNP concentration was prospectively measured in consecutive patients receiving either HD or CAPD at our hospital center. All other standard clinical parameters were recorded. The correlation between plasma NT-proBNP concentration and the type of dialysis was then examined. Results. We studied 99 consecutive patients on HD (age 62 +/- 15 years, 66% male) and 18 consecutive patients on CAPD (age 56 +/- 18 years, 67% male). Both groups had similar baseline characteristics including duration of dialysis, left ventricular function and mass, and cardiothoracic ratio. Significantly more patients on HD had abnormal NTproBNP levels compared to patients on CAPD (97% vs 44%; P<0.0001), and this difference remained highly significant when using various NT-proBNP cut off values. A subgroup analysis revealed that the lower NT-proBNP levels of CAPD patients are most pronounced in patients with preserved left ventricular ejection function. As expected, NT-proBNP levels correlated negatively with left ventricular function and positively with cardiothoracic ratio, and this applied to both HD and CAPD groups. Conclusion. The lower concentration of NT-proBNP in patients on CAPD compared to those on HD suggests that CAPD produces lesser hemodynamic stress, especially in patients with preserved left ventricular systolic function. Even though increased NT-proBNP levels have been shown to predict increased morbidity and mortality, further studies are necessary to assess the long term benefit of CAPD compared to HD.
VytisknoutZobrazeno: 12. 10. 2024 01:17